&nbsp;

IMPACT_Newsletter_Second_Edition

Nov 2019

Document

IMPACT_Newsletter_Third_Edition

Nov 2019

Document

IMPACT_Newsletter_Fourth_Edition

Nov 2019

Document

IMPACT_Newsletter_Fifth_Edition

Nov 2019

Regimen

CRBPETOP+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CRBPETOP(PO)+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CISPETOP(IND)

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Adjuvant, Curative

Drugs Used:

CISplatin,

etoposide

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2019

Regimen

CRBPPACL+ATEZBEVA

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

PACLitaxel,

CARBOplatin,

atezolizumab (Unfunded),

bevacizumab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

May 2020

Regimen

CRBPDOCE+PERT+TRAS

Cancer Type:

Breast

Intent: Curative, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

DOCEtaxel,

CARBOplatin,

PERTuzumab (Unfunded),

trastuzumab

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2022

Document